Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Rare Dankness is a Colorado cannabis genetics and cultivation company founded in 2010 by Scott Reach. The business focuses on breeding, preserving, and commercializing proprietary cannabis strains and seeds, and has also operated cultivation and dispensary activities associated with the House of Dankness brand. Its offerings center on cannabis flower, seeds, and related branded products rather than regulated biopharmaceutical therapeutics. The company is well known in the cannabis community for strains such as Ghost Train Haze, Scott's OG, Starkiller, and other proprietary genetics. Based on available public information, Rare Dankness is an active cannabis company, not a life science, biotech, pharma, or healthcare company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Rare Dankness.